Role of pharmacist in diabetes management at community pharmacy

Not Applicable

Completed

• Conditions: Type 2 diabetes mellitus; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN10671625
• Lead Sponsor: The Islamia University of Bahawalpur

Brief Summary

2021 Results article in https://doi.org/10.1177/00469580211036283 (added 15/06/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-05-16
• Study Completion: 2017-08-30
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Patients with type 2 diabetes mellitus (T2DM) diagnosed by a registered medical practitioner
2. Minimum one year T2DM history
3. Age 18-70 years
4. On anti-diabetes therapy
5. Co-morbidity may or may not be present
6. Minimum two follow-up visits within one month period from the date of registration in trial
7. Both male and female

Exclusion Criteria

1. Type 1 diabetes
2. Diabetes insipidus
3. Gestational diabetes and other forms of diabetes
4. Age <18 and >70
5. Not on anti-diabetic therapy
6. Less than two follow-up visits within one month period from the date of registration in trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Glycemic control, measured using the strip method Accu check performa meter at baseline and after the completion of 1 month of intervention <br>2. Patient satisfaction about the services provided during trial, measured using the DDSM-Q after the completion of 1 month of intervention

Secondary Outcome Measures

Name	Time	Method
1. Perception of self-management of diabetes, measured using the DDSM-Q<br>2. Disease state knowledge, measured using the DDSM-Q<br>3. Quality of life, measured using the EQ-5D-3L<br>4. Medication adherence, measured using the MMAS<br>Measured at baseline and after completion of 1 month of intervention